Marc Rivière
Gründer bei MRCL, Inc.
Profil
Marc Rivière founded MRCL, Inc., where he worked as President.
Dr. Rivière also currently works at GLWL Research, Inc., as Director, Esperas Pharma Inc., as Director, AL-S Pharma AG, as Director, Access Vascular, Inc., as Director, Festival Classica, Inc., as Director, and ImmunoRx Pharma, Inc., as Director.
Dr. Rivière also formerly worked at Xenon Pharmaceuticals, Inc., as Chief Executive Officer, Quintiles, Inc. (California), as Executive Vice President & Regional Director, ABIONYX Pharma SA, as Director, Mediti Pharma, Inc., as Director, Optina Diagnostics, Inc., as Director, Aptalis Pharma Canada ULC, as Vice President-Clinical Development, Æterna Zentaris, Inc., as Vice President-Clinical Affairs, Telesta Therapeutics, Inc., as Chief Medical Officer, and Caprion Pharmaceuticals, Inc., as Senior Vice President-Clinical Development.
Dr. Rivière received his undergraduate degree from Université de Bordeaux and doctorate degree from Université Toulouse III - Paul Sabatier.
Aktive Positionen von Marc Rivière
| Unternehmen | Position | Beginn |
|---|---|---|
GLWL Research, Inc.
 GLWL Research, Inc. Medical/Nursing ServicesHealth Services GLWL Research, Inc. is a medical research laboratory. It develops and proofs compounds for treatment of diabetes where it has developed an investigational compound known as GLWL-01 to treat type-2 diabetes. The company is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - |
Esperas Pharma Inc.
 Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - |
AL-S Pharma AG
 AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Direktor/Vorstandsmitglied | - |
MRCL, Inc.
 MRCL, Inc. Miscellaneous Commercial ServicesCommercial Services MRCL, Inc. provides research laboratory services. The private company is based in Montréal, Canada. The Canadian company was founded by Marc Rivière. | Gründer | - |
Festival Classica, Inc.
 Festival Classica, Inc. Media ConglomeratesConsumer Services Festival Classica, Inc. conducts events and musical shows. The private company is based in Saint-Lambert, Canada. | Direktor/Vorstandsmitglied | - |
ImmunoRx Pharma, Inc.
 ImmunoRx Pharma, Inc. Pharmaceuticals: MajorHealth Technology ImmunoRx Pharma, Inc. manufactures pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Juan Felipe Velasquez. | Direktor/Vorstandsmitglied | - |
Access Vascular, Inc.
 Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marc Rivière
| Unternehmen | Position | Ende |
|---|---|---|
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Mediti Pharma, Inc.
 Mediti Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mediti Pharma, Inc. develops, manufactures and sells pharmaceutical products. The company was founded in 2016 and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | - |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Marc Rivière
| Université de Bordeaux | Undergraduate Degree |
| Université Toulouse III - Paul Sabatier | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| AETERNA ZENTARIS INC. | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Aptalis Pharma Canada ULC provided pharmaceutical products. The company was founded in 1982 and was headquartered in Mount Saint-Hilaire, Canada. | Health Technology |
MRCL, Inc.
MRCL, Inc. Miscellaneous Commercial ServicesCommercial Services MRCL, Inc. provides research laboratory services. The private company is based in Montréal, Canada. The Canadian company was founded by Marc Rivière. | Commercial Services |
GLWL Research, Inc.
GLWL Research, Inc. Medical/Nursing ServicesHealth Services GLWL Research, Inc. is a medical research laboratory. It develops and proofs compounds for treatment of diabetes where it has developed an investigational compound known as GLWL-01 to treat type-2 diabetes. The company is headquartered in Montreal, Canada. | Health Services |
Esperas Pharma Inc.
Esperas Pharma Inc. Pharmaceuticals: MajorHealth Technology Esperas Pharma, Inc. manufactures and develops pharmaceutical products. The firm is created to develop one compound to proof-of-concept. It plans to develop, to proof-of-concept, a compound originally discovered through one of Lilly’s research and development programs, with the potential to treat certain types of cancers including triple negative breast cancer. The company was founded in 2015 and is headquartered in Montreal, Canada. | Health Technology |
AL-S Pharma AG
AL-S Pharma AG Pharmaceuticals: MajorHealth Technology AL-S Pharma AG engages in the development and marketing of pharmaceutical products. The company was founded by Michael Salzmann on September 19, 2016 and is headquartered in Schlieren, Switzerland. | Health Technology |
Optina Diagnostics, Inc.
 Optina Diagnostics, Inc. Medical SpecialtiesHealth Technology Optina Diagnostics, Inc. manufactures retinal diagnostic imaging devices to detect alzheimer's diseases. The company is headquartered in Montréal, Canada. | Health Technology |
Caprion Pharmaceuticals, Inc.
 Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Caprion Pharmaceuticals, Inc. discovered and developed pharmaceutical products. It offered a proprietary therapeutic pipeline in oncology and infectious diseases. Caprion Pharmaceuticals proteomics discovery technologies used to enable the discovery of novel targets for therapeutics development and the identification of novel protein biomarkers that can significantly enhance clinical development productivity and decision making. The company was founded in 1998 and was headquartered in Montreal, Canada. | Health Technology |
Festival Classica, Inc.
Festival Classica, Inc. Media ConglomeratesConsumer Services Festival Classica, Inc. conducts events and musical shows. The private company is based in Saint-Lambert, Canada. | Consumer Services |
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Mediti Pharma, Inc.
Mediti Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mediti Pharma, Inc. develops, manufactures and sells pharmaceutical products. The company was founded in 2016 and is headquartered in Montréal, Canada. | Health Technology |
ImmunoRx Pharma, Inc.
ImmunoRx Pharma, Inc. Pharmaceuticals: MajorHealth Technology ImmunoRx Pharma, Inc. manufactures pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Juan Felipe Velasquez. | Health Technology |
Access Vascular, Inc.
Access Vascular, Inc. Medical SpecialtiesHealth Technology Access Vascular, Inc. engages in the development and manufacture of medical devices. It provides hydrogel-based medical devices, such as catheter and stenst to improve venous access. The firm also improves peripherally inserted central catheter, hemodialysis, implantable ports, and drug delivery devices. The company was founded by James Biggins in 2015 and is headquartered in Bedford, MA. | Health Technology |
